Literature DB >> 18651673

Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells.

Anne-Sophie Vercoutter-Edouart1, Marie-Christine Slomianny, Olivia Dekeyzer-Beseme, Jean-François Haeuw, Jean-Claude Michalski.   

Abstract

Aberrant glycosylation of proteins is known to profoundly affect cellular adhesion or motility of tumoral cells. In this study, we used HT-29 human colon epithelial cancer cells as a cellular model of cancer progression, as they can either proliferate or differentiate into enterocyte phenotype. A glycoproteomic approach based on Con A lectin-affinity chromatography, SDS-PAGE and MS analysis, allowed the identification of membrane N-glycoproteins from Triton X-100-solubilized proteins from membrane preparation. Among them, 65% were membrane proteins, and 45% were known to be N-glycosylated, such as alpha chains integrin and dipeptidyl isomerase IV. By lectin-blot analysis, significant changes of alpha-2,3- and alpha-2,6-sialylation of membrane glycoproteins were observed between proliferating and differentiated HT-29 cells. From these results, nano-LC-MS/MS analysis of the tryptic digests of the corresponding bands was performed and led to the identification of several transmembrane glycoproteins, like members of the solute carrier family and adhesion proteins. Finally, we compared N-glycans profiles and monosaccharide composition of proliferating and enterocyte-like HT-29 cells using MALDI-MS and GC-MS analyses of permethylated derivatives. This glycomic approach allowed to underscore significant changes in N-glycans structure, in particular the expression of atypical N-acetylglucosamine (GlcNAc)-ended N-glycans in enterocyte-like HT-29 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651673     DOI: 10.1002/pmic.200800151

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  28 in total

Review 1.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

Review 2.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

Review 3.  Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.

Authors:  Noelle M Griffin; Jan E Schnitzer
Journal:  Mol Cell Proteomics       Date:  2010-06-14       Impact factor: 5.911

4.  N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes.

Authors:  Sally J Deeb; Juergen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2013-11-04       Impact factor: 5.911

Review 5.  Challenges in plasma membrane phosphoproteomics.

Authors:  Benjamin C Orsburn; Luke H Stockwin; Dianne L Newton
Journal:  Expert Rev Proteomics       Date:  2011-08       Impact factor: 3.940

6.  Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.

Authors:  Helene Bayer; Katharina Essig; Sven Stanzel; Martin Frank; Jeffrey C Gildersleeve; Martin R Berger; Cristina Voss
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

7.  Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities.

Authors:  Christoph Geisler; Donald L Jarvis
Journal:  Glycobiology       Date:  2011-08       Impact factor: 4.313

8.  Glycomic profiling of tissue sections by LC-MS.

Authors:  Yunli Hu; Shiyue Zhou; Sarah I Khalil; Calvin L Renteria; Yehia Mechref
Journal:  Anal Chem       Date:  2013-03-26       Impact factor: 6.986

9.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

Review 10.  Defining putative glycan cancer biomarkers by MS.

Authors:  Yehia Mechref; Yunli Hu; Aldo Garcia; Shiyue Zhou; Janie L Desantos-Garcia; Ahmed Hussein
Journal:  Bioanalysis       Date:  2012-10       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.